Nilo Therapeutics launches with $101 million Series A financing to advance a new class of ...

Retrieved on: 2025-10-09 02:36:01

Tags for this article:

Click the tags to see associated articles and topics

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of .... View article details on hiswai:

Excerpt

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments. press ...

Article found on: koreabizwire.com

View Original Article